U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Development Tool (DDT) Qualification Programs
  5. DDT COA #000122: Telemedicine-based Administration of the Montgomery-Asberg Depression Rating Scale (MADRS)
  1. Drug Development Tool (DDT) Qualification Programs

DDT COA #000122: Telemedicine-based Administration of the Montgomery-Asberg Depression Rating Scale (MADRS)

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Neuroscience (ON)
Division of Psychiatry (DPP)

DDT COA Number
DDT COA #000122

Instrument Name
Telemedicine-based Administration of the Montgomery-Asberg Depression Rating Scale (MADRS)

Disease/Condition
Major Depressive Disorder (MDD)

Concept of Interest
Signs and symptoms of depression

Context of Use
Adults (18-65 years) with MDD treated in an ambulatory setting and who have experienced a major depressive episode within the previous 6 months

COA Type
ClinRO

Qualification Stage
Letter of Intent- Not Accepted

Requestor(s)
Science 37

Contact(s)
Lisa DiMolfetto

Date Accepted into CDER’s COA Qualification Program
N/A

Submission and Regulatory Correspondence History

Qualification Submission Date FDA Submission Decision & Recommendations Date
Letter of Intent 10/11/19 FDA Response (Not Accepted) 2/3/20